Abstract
In this issue of Blood, Oevermann et al report on a cohort of 85 children (median age, 10 years) undergoing T-cell-depleted haploidentical hematopoietic cell transplantation (HCT) for acute lymphoblastic leukemia (ALL), where variations in the killer-cell immunoglobulin-like receptor (KIR) gene "content" of the donor were associated with significantly less relapse and improved disease-free survival.
Original language | English (US) |
---|---|
Pages (from-to) | 2623-2624 |
Number of pages | 2 |
Journal | Blood |
Volume | 124 |
Issue number | 17 |
DOIs |
|
State | Published - Oct 23 2014 |
Bibliographical note
Publisher Copyright:© 2014 by The American Society of Hematology.